Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated R-CHOP ± Radiotherapy: An International Multi-Centre Retrospective Study

July 9, 2019

Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris Van Vliet, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Pedro Farinha, Jorne Lionel Biccler, Joseph M Connors, David W. Scott, Kerry J Savage, Tarec Christoffer El-Galaly, Diego Villa and Chan Yoon Cheah

Click here for further information